GSK3β指导染色体修复途径的选择,以支持BRCA1-独立的PARP抑制剂敏感性
Justin W Leung1, David Gius1,2
1Department of Radiation Oncology, Mays Cancer Center at University of Texas Health San Antonio MD Anderson, Joe R. and Teresa Lozano Long School of Medicine, San Antonio, Texas, USA.
The Journal of clinical investigation
|November 17, 2025
概括
糖原合成酶激酶-3β (GSK3β) 通过酸化53BP1.1来调节DNA修复路径的选择. 这种酸化将DNA双链断裂修复转向同源重组,影响癌症治疗.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 遗传学 遗传学 是一个
背景情况:
- 糖原合成酶激酶-3β (GSK3β) 是DNA双链断裂 (DSB) 修复中的关键调节剂.
- 瘤抑制剂p53结合蛋白1 (53BP1) 在DSB修复途径选择中起着至关重要的作用.
研究的目的:
- 阐明GSK3β影响DSB修复路径选择的机制.
- 调查53BP1酸化在氨酸334 (T334) 中在调节非同源端连接 (NHEJ) 和同源重组 (HR) 中的作用.
主要方法:
- 在T334.1对53BP1的特定位点酸化分析.
- 研究化53BP1与下游合作伙伴PTIP和RIF1.1的相互作用.
- 评估CtIP和RPA32在DNA损伤部位的使用情况.
- 利用缺乏53BP1 T334A突变体研究其对DNA修复的影响.
主要成果:
- 通过GSK3β介导的53BP1 T334酸化通过防止与PTIP和RIF1.1的相互作用来抑制53BP1导向的NHEJ.
- 这种酸化促进HR,通过促进CtIP和RPA32在DNA损伤部位的招募.
- 一种缺乏的53BP1 T334A突变体在DSB中显示出异常积累,损害了末端切除和抑制HR.
结论:
- 通过53BP1酸化,GSK3β作为NHEJ和HR之间DSB修复路径选择的关键决定因素.
- 针对GSK3β/53BP1轴是一个潜在的治疗策略,可以提高PARP抑制剂在固体瘤中的疗效,无论BRCA1状态如何.
相关概念视频
Long-patch Base Excision Repair
7.8K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.8K
Restarting Stalled Replication Forks
6.2K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
6.2K
DNA Damage can Stall the Cell Cycle
9.9K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.9K
DNA Damage Can Stall the Cell Cycle
3.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K
Base Excision Repair
25.9K
One of the common DNA damages is the chemical alteration of single bases by alkylation, oxidation, or deamination. The altered bases cause mispairing and strand breakage during replication. This type of damage causes minimal change to the DNA double helix structure and can be repaired by the base excision repair (BER) pathways. BER corrects damaged DNA sequences by removing the damaged base and restoring the original base sequence using the complementary strand as a template.
The first step of...
The first step of...
25.9K
Homologous Recombination
62.5K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
62.5K


